Great Hill Invests $100 Million In IVX Health, An Outpatient Infusion Provider Organization

IVX Health, which provides outpatient infusion centers nationwide, completed a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies. Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital. IVX Health intends to use the funding to accelerate entry into new markets in 2022. Mark Taber, a managing director at Great Hill Partners, will join IVX Health’s Board of Directors.

IVX Health provides infusion and injection therapy for people with complex chronic conditions such as rheumatoid arthritis . . .